NASDAQ
QDEL
Last Price
US $17.66
KEY FIGURES
MKT CAP
$1.2B
EPS
TTM
$-17.76
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
0.45x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
QuidelOrtho Corporation cash flow to debt ratio of 3.71% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
QuidelOrtho Corporation's free cash flow has increased -25.96% from $-112.10M last year to $-83.00M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
QuidelOrtho Corporation's debt to equity ratio is 1.55, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
QuidelOrtho Corporation's debt has increased relative to shareholder equity from 0.90 last year to 1.55 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
QuidelOrtho Corporation has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
QuidelOrtho Corporation's interest coverage ratio is -5.25, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
QuidelOrtho Corporation's profit margin has increased (-38.20%) in the last year from -73.74% to -45.57%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
QuidelOrtho Corporation's short-term assets of $1.45G exceed its short-term liabilities of $966.10M
Decreasing performance - ROA.
QuidelOrtho Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
QuidelOrtho Corporation's return on equity of -56.31%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
QuidelOrtho Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
QuidelOrtho Corporation had positive net income in only 2.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
QuidelOrtho Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
QuidelOrtho Corporation has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
QuidelOrtho Corporation's yearly earnings has increased -44.84% since last year from $-2.05G to $-1.13G, signaling increasing performance
Decreasing performance - Healthy revenue growth.
QuidelOrtho Corporation's yearly revenue has decreased -1.89% since last year from $2.78G to $2.73G, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -19.88% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
QuidelOrtho Corporation's 3-year revenue CAGR of -5.80% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
QuidelOrtho Corporation had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Decreasing performance - ROE consistency.
QuidelOrtho Corporation had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
QuidelOrtho Corporation has insufficient data to evaluate this check.
Overvalued - Earnings yield.
QuidelOrtho Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
QuidelOrtho Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
QuidelOrtho Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
QuidelOrtho Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
QuidelOrtho Corporation has a price-to-book ratio of 0.65x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
QuidelOrtho Corporation has a price-to-sales ratio of 0.45x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-56.31%
Return on equity
ROIC: -19.88%
Valuation History
-1.0X
Price to Earnings
EV/EBITDA: -7.3X
Cash flow
Profit margin
10.44%
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $17.66
—
Default assumptions
EBITDA Multiple
Fair Value
Market $17.66
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.